Skip to main content
. 2016 Mar 25;95(12):e3234. doi: 10.1097/MD.0000000000003234

FIGURE 3.

FIGURE 3

The change of ADMA/NOx ratio from baseline to end of study for responders to AM monotherapy and responders to AM combined with DXM respectively. “AM” represented as the responders to amlodipine monotherapy (N = 29). “AM + DXM” represented as the responders to amlodipine combined with dextromethorphan (N = 25).